Company: NDRA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001654954-25-003612
Chunk: 494

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 2
Chunk 494
---
 Data” at Item 8 and incorporated herein by reference)

2. Financial Statement Schedules (Schedules to the Financial Statements have been omitted because the information required to be set forth therein is not applicable or is shown in the accompanying Financial Statements or notes thereto)

3. Exhibits

The following is a list of exhibits filed as part of this Annual Report:

ExhibitNumber Exhibit DescriptionFiled HerewithIncorporation by ReferenceFormExhibitFiling Date3.1Fourth Amended and Restated Certificate of Incorporation of the Company, as amended [Restated for SEC filing purposes only]x   3.2Amended and Restated Bylaws of the Company S-13.412/06/164.1Specimen Certificate representing shares of common stock of the Company S-14.111/21/164.2Certificate of Designations of Series A Convertible Preferred Stock 8-K4.112/11/194.3Form of Warrant issued in December 2019 Series A Convertible Preferred Stock Offering 8-K4.212/11/194.4Certificate of Designations of Series B Convertible Preferred Stock 8-K4.112/26/194.5Form of Warrant issued in December 2019 Series B Convertible Preferred Stock Offering 8-K4.212/26/194.6Certificate of Designations of Series C Preferred Stock 8-K3.109/27/224.7Form of Warrant issued in April 2023 Underwritten Public Offering S-14.203/30/234.8Form of Underwriter’s Warrant issued in April 2023 Underwritten Public Offering S-1/A4.304/18/234.9Form of Warrant Agency Agreement S-14.403/30/234.10Form of Placement Agent Warrant S-14.505/10/244.11Form of Series A Warrant S-14.205/31/244.12Form of Series B Warrant  S-14.305/31/244.13Form of Pre-Funded Warrant S-14.405/10/244.14Amendment to Series A Warrant 10-Q3.808/14/244.15Amendment to Series B Warrant 10-Q3.908/14/244.16Description of Securities 10-K4.1203/30/2210.1ENDRA Life Sciences Inc. 2016